The PGE2 synthesis enzyme COX-2, a target for non-steroidal antiinflammatory drugs including selective inhibitors, emerged as one such factor (7, 21) and has been shown to support an immunosuppressive TME in other cancer types as well (10, 34, 51). The gene discussed is PTGS2; the disease is cancer.